Tumour-associated and non-tumour-associated microbiota: Addendum
- PMID: 29420132
- PMCID: PMC6219647
- DOI: 10.1080/19490976.2018.1435246
Tumour-associated and non-tumour-associated microbiota: Addendum
Abstract
In a recent study1 we reported that tissue-associated microbial Co-abundance Groups (CAGs) were differentially associated with colorectal cancer (CRC). Two of the CAGs, which we named Pathogen CAG and Prevotella CAG, were correlated with a gene expression signature indicative of a TH17 response. A TH17 response has been associated with decreased survival in patients with CRC2, and members of the Pathogen CAG such as Fusobacterium nucleatum, Escherichia coli and Bacteroides fragilis have been repeatedly reported to be associated with CRC-development. Thus we hypothesized that the abundance of these CAGs may be associated with poor survival. In this Addendum we extend our analysis of the at-surgery microbiota to microbiota profiles obtained after surgery for CRC which we analyzed in the context of survival data for patients with CRC. Surprisingly we found that high tissue-associated abundance of the previously defined Prevotella- and Pathogen-CAGs at surgery was associated with longer survival. Furthermore, we detected an association of the Bacteroidetes CAG in pre-surgery faecal microbiota with stability of the microbiota after surgery.
Keywords: colorectal cancer; gut microbiota; survival.
Figures
References
-
- Flemer B, Lynch DB, Brown JM, Jeffery IB, Ryan FJ, Claesson MJ, O'Riordain M, Shanahan F, O'Toole PW. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut [Internet]. 2017;66:633–43. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26992426. doi: 10.1136/gutjnl-2015-309595. - DOI - PMC - PubMed
-
- Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman W-H, Pagès F, et al.. Clinical impact of different classes of infiltrating t cytotoxic and helper cells (th1, th2, treg, th17) in patients with colorectal cancer. Cancer Research [Internet]. 2011;71:1263–71. Available from: http://cancerres.aacrjournals.org/content/71/4/1263. doi: 10.1158/0008-5472.CAN-10-2907. - DOI - PubMed
-
- Arumugam M, Raes J, Pelletier E, Le Paslier D Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M, et al.. Enterotypes of the human gut microbiome. Nature [Internet] 2011; 473:174–80. Available from: https://doi.org/ 10.1038/nature09944. doi: 10.1038/nature09944. - DOI - PMC - PubMed
-
- Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, et al.. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut [Internet]. 2016;65:1973–80. Available from: http://gut.bmj.com/content/65/12/1973 doi: 10.1136/gutjnl-2015-310101. - DOI - PMC - PubMed
-
- Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, et al.. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell [Internet]. XXXX;170:548–563.e16. Available from: https://doi.org/ 10.1016/j.cell.2017.07.008 doi: 10.1016/j.cell.2017.07.008. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical